Tolerance to neuroleptics, deficit syndrome and cognitive functions, in schizophrenia;Tolerance aux neuroleptiques, deficit et fonctions cognitives

Encephale

Volumn 22, Issue SPEC. ISS. 2, 1996, Pages 49-54

  Kahn, J P ^a  

^a Ctr Hospitalier Univ de Nancy   (France)

Author keywords

cognitive functions; deficit syndrome; negative symptoms; neuroleptics

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

COGNITIVE DEFECT; CONFERENCE PAPER; DRUG TOLERABILITY; HUMAN; NEGATIVE SYNDROME; PATHOPHYSIOLOGY; SCHIZOPHRENIA; TASK PERFORMANCE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DEPRESSION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; REVIEW; RISK FACTOR;

ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; DEPRESSION; HUMANS; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0029834222     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. ADDINGTON J, ADDINGTON D, MATICKA-TYNDALE E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr Res 1991 ; 5 : 123-34.
2. ANDREASEN NC, GROVE MD. Evaluation of positive and negative symptoms in schizophrenia. Psychiatr Psychobiol 1986 ; 1 : 108-21.
3. BILDER RM, LIPSCHUTZ-BROCH L, REITER G. et al. Intellectual deficits in first episode schizophrenia : evidence for progressive deterioration. Schizophr Bull 1992 ; 18 : 437-48.
4. BRAFF DL. Impaired speed of information processing in non-medicated schizotypal patients. Schizophr Bull 1981 ; 7 : 499-508.
5. BRAFF DL. Sensory input deficits and negative symptoms in schizophrenic patients. Am J Psychiatry 1989 ; 146 : 1006-11.
6. BRAFF DL. Information processing and attention dysfunctions in schizophrenia. NIH-NIMH Special report : Schizophrenia 1993. Schizophr Bull 1993 ; 19 : 59-85.
7. BREIER A, WOLKOWITZ OM, DORAN AR et al. Neuroleptic responsivity of negative and positive symptoms in schizophrenia. Am J Psychiatry 1987 ; 144 : 1549-55.
8. CARPENTER WT Jr, BUCHANNAN RW, KIRKPATRICK B et al. Negative symptoms : a critique of current approaches. In : « Negative versus Positive Symptoms », Maneros A, Andreasen NC and Tsuang MT, editors, Berlin : Springer Verlag, 1991, pp. 126-133.
9. CASSENS G, INGLIS AK, APPELBAUM PS, GUTHEIL TG. Neuroleptics : effects on neurospychological function in chronic schizophrenic patients. Schizophr Bull 1990 ; 16 : 477-99.
10. COSTELLO CG. Research symptoms versus research on syndromes : arguments in favor of allocating more time to the study of symptoms. Br J Psychiatry 1992 ; 160 : 304-8.
11. CROW TJ. The two-syndrome concept : origins and current status. Schizophr Bull 1985 ; 11 : 471-86.
12. FRITH CD, DONE JD. Towards a neuropsychology of schizophrenia. Br J Psychiatry 1988 ; 153 : 437-43.
13. GOLDBERG E. Akinesia, tardive dementia and frontal lobe disorder in schizophrenia. Schizophr Bull 1985 ; 11 : 255-63.
14. GOLDBERG SC. Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 1985 ; 11 : 453-6.
15. GOLDSTEIN G, HALPERIN KM. Neuropsychological differences among subtypes of schizophrenia. J Abnorm Psychol 1977 ; 86 : 34-40.
16. GRAY JA, FELDON J, RAWLINS JNP, HEMSLEY DR, SMITH AD. The neuropsychology of schizophrenia. Behav Brain Sci 1991 ; 14 : 1-84.
17. GREEN M, WALKER E. Attentionnal performance in positive and negative symptoms schizophrenia. J Nerv Ment Dis 1986 ; 174 : 208-13.
18. HAGGER C, BUCKLEY P, KENNY JT et al. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatr 1993 ; 34 : 702-12.
19. HOFF AI, RIORDAN H, O'DONNELL DW, MORRIS L, DE LISI LE. Neuropsychological functionning of first episode schizophreniform patients. Am J Psychiatry 1992 ; 149 : 898-903.
20. JOHNSTONE EC, CROW TM, FRITH CD, OWENS DGC. Adverse effects of anticholinergic medication in positive schizophrenic symptoms : theoretical and practical considerations. Psychol Med 1983 ; 13 : 523-7.
21. KANE JM, MAYERHOFF D. Do negative symptoms respond to pharmacological treatment ? Br J Psychiatry 1989 ; 155 (suppl. 7) : 115-8.
22. KING DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990 ; 157 : 799-811.
23. KING DJ, HENRY G. The effect of neuroleptics on cognitive and psychomotor function. A preliminary study in healthy volunteers. Br J Psychiatry 1992 ; 160 : 647-53.
24. LIDSKY TI, LABUSZEWSKI T, LEWINE FM. Are movement disorders the most serious side effects of maintenance therapy with antipsychotic drugs ? Biol Psychiatry 1981 ; 16 :1189-94.
25. MAC GHIE A, CHAPMAN J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961 ; 34 : 103-16.
26. MEDALIA A, GOLD J, MERRIAM A. The effects of neuroleptics on neuropsychological tests results of schizophrenics. Arch Clin Neuropsychol 1988 ; 3 : 249-71.
27. MELTZER HY, SOMMERS AA, LUCHINS DJ. The effects of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Psychopharmacol 1986 ; 6 : 329-38.
28. NUECHTERLEIN KH, EDELL WS, NORRIS M, DAWSON ME. Attentional vulnerability indicators, thought disorder and negative symptoms. Schizophr Bull 1986 ; 12(3) : 408-26.
29. SIEVER LJ. The biology of the boundaries of schizophrenia. In : « Advances in Neuropsychiatry and Psychopharmacology : Schizophrenia Research », Tamminga CA, Schulz SC editors, New York : Raven Press, 1991, vol. 1, pp. 181-92.
30. SPOHN HE, STRAUSS ME. Relation of neuroleptic and anticholinergic medication to cognitive function in schizophrenia. J Abnorm Psychol 1989 ; 98 : 367-80.
31. STRAUSS ME. Relations of symptoms to cognitive deficits in schizophrenia. NIH-NIMH Special report : Schizophrenia 1993. Schizophr Bull 1993 ; 19 : 41-57.
32. SWERDLOW NR, CAINE SB, BRAFF DL, GEYER MA. The neural substrates of sensorimotor gating of the startle reflex : a review of recent findings and their implications. Psychopharmacology 1992 ; 6 : 176-90.
33. TANDON R, GREDEN TF. Cholinergic hyperactivity and negative schizophrenic symptoms. Arch Gen Psychiatry 1989 ; 46 : 745-53.
34. WALKER E, LEWINE RJ. Negative symptom distinction in schizophrenia : validity and etiological relevance. Schizophr Res 1988 ; 1 : 315-28.
35. ZAHN TP, CARPENTER WT Jr, MCGLASHAN TH. Short-term outcome, clinical improvement, and reaction time performance in acute schizophrenia. In : « The nature of schizophrenia : new approaches to research and treatment », Wynne LC, Cromwell RL, Matthysse S. editors, New York : John Wiley and Sons, 1979, pp. 273-79.